Could new drug halt Philippine HIV rise?
Media playback is unsupported on your device

Could new drug halt Philippine HIV rise?

The anti-HIV drug PrEP is being offered to 200 gay men and transgender women in the Philippines as part of a trial to curb the rapid spread of HIV there.

A recent UN report found the country had the highest HIV infection growth rate in the Asia-Pacific region.

'Project PrEPPY' is being organised by the World Health Organisation and amfAR, an American AIDS research charity.

One man, 'Rodolfo', tells us why he is taking part in the trial.

Produced by Howard Johnson

  • 05 Sep 2017
Go to next video: How PrEP changed Matt's life